Replies to post #208678 on Biotech Values

[WorstLuck]

Someone else with better knowledge of the NASH landscape might have a comment on that.

There is a lot of unmet need in NASH. So I would expect more BTD designations until the need is better met.

[DewDiligence]

Will all NASH compounds receive BTD?

Certainly not all of them. I'm expecting the FDA's awarding of BTD for NASH compounds to parallel the way the FDA handled HCV, where drug combinations rather than individual drugs were the recipients of most the BTD awards.